Drug Development and Registration: Challenges and Opportunities in Ovarian Cancer

    loading  Checking for direct PDF access through Ovid

Abstract

Many challenges and opportunities present themselves for improving the care and outcome of patients with ovarian cancer. Open, ongoing discussion between regulatory, National Cancer Institute, academic, and pharmaceutical investigators and scientists will lead to benefit and an enhanced understanding of ovarian cancer.

See also pages 2604-8

Related Topics

    loading  Loading Related Articles